Is there a generic for Cupric chloride?

Yes. The FDA Orange Book lists 4 approved generic (ANDA) applications for Cupric chloride, referencing the brand CUPRIC CHLORIDE IN PLASTIC CONTAINER. Generics rated with an "A" therapeutic-equivalence code are considered substitutable for the brand.

What is the reference-listed drug for Cupric chloride?

CUPRIC CHLORIDE IN PLASTIC CONTAINER (NDA 018960, HOSPIRA) is the reference-listed drug — the approved product a generic applicant must show its version is the same as.

What dosage forms of Cupric chloride are approved?

Cupric chloride is approved in the following dosage form: injectable.

FDA Orange Book · active-ingredient family

Cupric chloride

Cupric chloride: 1 brand, 4 generics; first approved Jun 26, 1986; generic available.

Generic availableHas discontinued products

Generic status & protection

Generic available — 4 ANDA applications approved.

Brands (NDA)

Generics (ANDA)

Listed patents

Presentations

Originator applications

Brand (NDA) products

CUPRIC CHLORIDE IN PLASTIC CONTAINERRLDRS

HOSPIRANDA 0189601986

Approved strengths under this FDA application.
Strength	Dosage form	Route	Status	TE
EQ 0.4MG COPPER/ML	INJECTABLE	INJECTION	Rx	AP

Abbreviated applications

Generic (ANDA) products (4)

CUPRIC CHLORIDE

AMNEALANDA 2172872026

Approved strengths under this FDA application.
Strength	Dosage form	Route	Status	TE
EQ 0.4MG COPPER/ML	INJECTABLE	INJECTION	Discontinued	—

CUPRIC CHLORIDE

SOMERSETANDA 2161132024

Approved strengths under this FDA application.
Strength	Dosage form	Route	Status	TE
EQ 0.4MG COPPER/ML	INJECTABLE	INJECTION	Rx	AP

CUPRIC CHLORIDE

STIRAANDA 2176262024

Approved strengths under this FDA application.
Strength	Dosage form	Route	Status	TE
EQ 0.4MG COPPER/ML	INJECTABLE	INJECTION	Rx	AP

CUPRIC CHLORIDE

EXELA PHARMAANDA 2120712022

Approved strengths under this FDA application.
Strength	Dosage form	Route	Status	TE
EQ 0.4MG COPPER/ML	INJECTABLE	INJECTION	Rx	AP

Orange Book patent file

Listed patents

No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.

FDA approval span

Approval history

First approval

Jun 26, 1986

40 yr 8 mo ago

Most recent approval

Jan 26, 2026

6 mo ago

Approvals span 1986–2026 across 5 FDA applications.

Brand (NDA) 120%

Generic (ANDA) 480%

Cupric chloride — frequently asked questions

Generics, reference-listed drug, patents, and exclusivity for this active ingredient, from the FDA Orange Book.

Built directly from the FDA Orange Book data file (products, patents, and exclusivity). TE codes, RLD/RS flags, patent expirations, and exclusivity dates match the official FDA record. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.

Related FDA reference tools

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.

Book a Demo